Startseite Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?

  • Ana Colmenares EMAIL logo , Laura González , Peter Gunczler und Roberto Lanes
Veröffentlicht/Copyright: 26. Juli 2012

Abstract

Aim: The aim of this study was to evaluate the effect of combined therapy with growth hormone (GH) and luteinizing hormone-releasing hormone agonist (LHRHa) on the near-final height (NFH) of children with idiopathic short stature (ISS) and growth hormone deficiency (GHD) in early puberty.

Methods: A retrospective analysis of 20 patients with ISS and 9 patients with GHD treated with combined therapy was undertaken. Twelve children with ISS and ten with GHD, treated with GH alone, served as controls. Patients were matched at baseline for chronological age, bone age, height standard deviation score (SDS), and pubertal development.

Results: Patients with ISS or GHD treated with combined therapy improved both their predicted adult height (PAH) at 2 years of therapy (ISS, p<0.001; GHD, p=0.03) and their NFH (ISS, p<0.05; GHD, p=0.05). Treatment with combined therapy did not generate additional benefits on the PAH after 2 years of therapy (ISS children, an increase of 7.9±4.9 cm with combined therapy vs. 7.3±6.0 cm with GH; GHD children, an increase of 6.8±7.8 cm with combined therapy vs. 5±5.9 cm with GH). The total height gain SDS was higher in patients treated with GH alone compared with those with combined therapy, but the difference was not significant (ISS children, a gain of 2.4 SDS with GH vs. 0.8 SDS with combined therapy; GHD children, a gain of 1.8 SDS with GH vs. 0.6 SDS with combined therapy).

Conclusions: Although 2 years of combined treatment with GH and LHRHa improved the PAH and the NFH of ISS and GHD patients in early puberty, this improvement was not significant compared with that observed in similar subjects treated with GH alone.


Corresponding author: Ana Colmenares, MD, Instituto Venezolano de los Seguros Sociales. Hospital Dr. Patrocinio Pe ñ uela Ruiz, Tachira, Venezuela 5001, Phone: +58 276 3563052, +58 414 0774242

Received: 2012-6-10
Accepted: 2012-6-23
Published Online: 2012-07-26
Published in Print: 2012-08-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Obesity, adolescence, and sleep deprivation
  5. Reviews
  6. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism
  7. Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts
  8. Images in pediatric endocrinology
  9. Adhesion of the labia minora in girls: a common disorder that is rarely considered
  10. Original articles
  11. Thyroid nodules in children and adolescents: a single institution’s experience
  12. Effects of selenium supplementation in the early stage of autoimmune thyroiditis in childhood: an open-label pilot study
  13. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method
  14. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
  15. Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism
  16. Association of vitamin D receptor gene Cdx2 polymorphism with bone markers in Turner syndrome patients
  17. Serum 25-hydroxyvitamin D levels do not correlate with asthma severity in a case-controlled study of children and adolescents
  18. Assessment of the 21-hydroxylase deficiency and the adrenal functions in young females with Turner syndrome
  19. The association of FGF23 levels in obese adolescents with insulin sensitivity
  20. Higher postprandial serum ghrelin among African-American girls before puberty
  21. Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents
  22. The second report from Turkey: waist percentiles for 6–11-year-old children in Elazig Province, Eastern Anatolia
  23. Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus
  24. Adiponectin and arterial stiffness in youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study
  25. Thyroid autoimmunity in 72 children with type 1 diabetes mellitus: relationship with pancreatic autoimmunity and child growth
  26. Nesfatin-1 in newborns: relationship with endocrine and metabolic and anthropometric measures
  27. How much is enough? Evaluation of adrenal function in children who undergo growth hormone stimulation test
  28. A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism
  29. Relation among ghrelin, nutritional status, and immunity in children
  30. The histopathological effects of tamoxifen in the treatment of pubertal gynecomastia
  31. Patient reports
  32. Central precocious puberty after interpersonal transfer of testosterone gel: just a coincidence?
  33. Elevated α-fetoprotein levels in Van Wyk-Grumbach syndrome: a case report and review of literature
  34. Identification of LDLR mutations in two Chinese pedigrees with familial hypercholesterolemia
  35. Foster care and type 1 diabetes in the Bronx: a case series
  36. Primary hyperparathyroidism: fifth parathyroid intrathymic adenoma in a young patient
  37. Sturge-Weber syndrome: presentation with partial hypopituitarism
  38. Self-limiting hematuria following growth hormone provocative testing with arginine hydrochloride
  39. First case report of short-chain acyl-CoA dehydrogenase deficiency in China
  40. Ganglioneuroblastoma in a young child with Turner syndrome
  41. MODY2 caused by a novel mutation of GCK gene
  42. Variability in the age at diagnosis of diabetes in two unrelated patients with a homozygous glucokinase gene mutation
  43. Letter to the editor
  44. Understanding less than nothing: high-dose vitamin D therapy for treating vitamin D deficiency
  45. Meetings
  46. Meetings Calendar
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0182/html
Button zum nach oben scrollen